Overview

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Status:
Completed
Trial end date:
2021-05-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Navipharm Corporation
Criteria
Inclusion Criteria:

- Subjects who have ability to comprehend the contents of study and before participating
in trial and have willingness to sign of informed consent in writing

- Subjects who have symptom of acute low back pain

Exclusion Criteria:

- Subjects who cannot prohibit anti-inflammatory drug or muscle relaxants during
clinical trial

- Inadequate subject for the clinical trial by the investigator's decision